SIALYL-DI-LEWIS A AS EXPRESSED ON GLYCOPROTEINS BUT NOT GLYCOLIPIDS AS A FUNCTIONAL CANCER TARGET AND ANTIBODIES THERETO

The present invention relates to an isolated specific binding member capable of binding sialyl-di-Lewisa, and associated treatments and pharamaceutical compositions for treatment of cancer. La présente invention concerne un élément de liaison spécifique isolé capable de se lier à la forme sialylée d...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	TIVADAR, Silvana, PARSONS, Tina, DURRANT, Lindy Gillian, MCINTOSH, Richard, VANKEMMELBEKE, Mireille
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to an isolated specific binding member capable of binding sialyl-di-Lewisa, and associated treatments and pharamaceutical compositions for treatment of cancer. La présente invention concerne un élément de liaison spécifique isolé capable de se lier à la forme sialylée du di-Lewis A, des traitements associés et des compositions pharmaceutiques pour le traitement du cancer.